Functional Gastrointestinal Disorders and Incidence of Type 2 Diabetes: Evidence from the E3N-EPIC Cohort Study
Guy Fagherazzi 1, 2 ; Gaëlle Gusto 1, 2 ; Beverley Balkau 1, 2 ; Marie-Christine Boutron-Ruault 1, 2 ; Françoise Clavel-Chapelon 1, 2 ; Fabrice Bonnet 1, 3 Type 2 diabetes (T2D) is one of the most frequent chronic diseases worldwide and its prevalence keeps increasing. 1 The International Diabetes Federation predicts an increase in the worldwide prevalence of T2D from 8.3% to 8.8% in people aged 20 to 79 years between 2013 and 2035, with 382 million people having T2D in 2013 and 592 million in 2035. 2 Diabetes has a high social and economic burden and even though primary and secondary preventions of diabetes are constantly improving, there is still a need for a better understanding of this disease. Similarly, functional gastrointestinal disorders (FGID) such as irritable bowel syndrome (IBS) are highly prevalent conditions, [3] [4] [5] and frequently accompanied with diarrhea or constipation. 5 The worldwide pooled prevalence of chronic idiopathic constipations has been estimated to be 14%. 3 The rate is higher in women and in individuals with low socioeconomic status. It increases with age and is countrydependent, with France ranking among the top countries. 3 In 1998, about 26 million French individuals were affected by at least one type of FGID. 6 A French study in 1998, based on a representative sample of the general population aged over 15 years, reported that among those with FGID, 35% had constipation and 28% had diarrhea, and that symptoms lasted 6 months to 5 years for 38% of subjects, and over 5 years for another 52%. 5 It is known that individuals with T2D have more frequent occurrences of diarrhea and constipation than the general population. [7] [8] [9] An estimated 76% of diabetic patients suffer from FGID, 10 which are partly attributed to the side effects of T2D treatments such as metformin 11 or insulin, 10 or to complications of T2D. Population studies have also shown that obesity is associated with a wide range of chronic gastrointestinal complaints, [12] [13] [14] [15] [16] [17] which supports the hypothesis that obesity and FGID are physiologically related. 4, 10, 11 To date, little is known on the longitudinal association of gastrointestinal disorders such as diarrhea and constipation and the risk of incident T2D. Hypotheses relating FGID and the microbiota have recently been proposed. 18 FGID and the microbiota are thought to share common features such as a genetic predisposal, which could then be involved in the genesis of immune-related disorders and diabetes. 19 Further, specific features of the microbiota have been associated with the development of T2D. 20, 21 However, to our knowledge, no study has ever evaluated whether FGID such as diarrhea and constipation could be associated with the risk of developing T2D. Therefore we analyzed the relation between FGID and incident T2D in the large prospective E3N-EPIC cohort study.
RESEARCH DESIGN & METHODS

Study population
The E3N study (Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l'Education Nationale) is a French prospective cohort study of 98 995 female teachers initiated in 1990 
Assessment of functional gastrointestinal disorders
Updated information on FGID was requested in the baseline questionnaire (1993) and in the four subsequent follow-up questionnaires (1995, 1997, 2000 and 2002) . Study participants answered the question "Which of the following best describes your bowel movements: normal, diarrhea, constipation, alternation diarrhea-constipation". Baseline characteristics of the study population according to this variable are provided in Table 1 .
Ascertainment of diabetes
Potential diabetes cases were identified first through self-reporting of diabetes in any of the 9 follow- period. Cases identified through the drug reimbursement file but who were reimbursed for antidiabetic drugs only once in the period and had declared to be non-diabetic were considered as non-cases.
For the present analysis, prevalent and non-validated diabetes cases were excluded from the analyses, leaving 1 795 validated incident cases during follow-up.
Statistical analysis Association between gastrointestinal transit and type 2 diabetes risk
Descriptive data were presented as mean (STD) and N (%). Cox multivariable regression models with age as the time scale were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) and are tabulated in Table 2 . Time at entry was the age at the beginning of follow-up, exit time was the age when participants were diagnosed with diabetes, died, were lost to follow-up, or were censored at the end of the follow-up period, whichever occurred first. The main exposure variable was FGID (normal/diarrhea/constipation/alternation diarrhea-constipation), which was modeled as a time-dependent variable, considering the "normal" category as the reference. Both age-adjusted (M 0 ) and multivariable models (M 1 ) were computed. Multivariable models were adjusted for established T2D risk factors: smoking status (nonsmoker/ ex-smoker/ current smoker, time-dependent), physical activity (continuous in Met-h/week, time-dependent), treated hypertension (yes, no, timedependent), treated hypercholesterolemia (yes, no, baseline), family history of diabetes (yes/no, baseline).
A similar analysis has been performed with overweight as the outcome instead of T2D to quantify the potential mediation by adiposity between FGID and T2D.
Sensitivity analyses
We fitted additional models (M 2 ) adjusted for dietary factors, considered as continuous variables: intake of ethanol (g/day), omega 3 fatty acids (g/day), carbohydrates (g/day), and energy from fat and protein (kcal/day), and consumption of coffee (mL/day), fruits and vegetables(g/day), and processed meat (g/day). Finally, as adiposity is a key factor in T2D etiology, we tested models (M 3 ) additionally adjusted for BMI (continuous, kg/m²). We also tested a potential interaction between FGID and BMI, which was shown to be not statistically significant (P inter =0.45).
To investigate potential reverse causation, we also evaluated the associations between FGID and T2D by excluding cases in the first five years of follow-up. We also computed Cox models starting in 1995 instead of 1993, where information on the use of laxatives and psychotropic drugs was available.
All statistical analyses used SAS 9.3 (SAS Institute Inc., Cary, NC, PHREG procedure for Cox models). All statistical tests were two-sided and considered as significant if the P-value<0.05.
RESULTS
Baseline characteristics
Compared to women with a normal gastrointestinal transit, those with chronic diarrhea were more frequently current smokers (15.6 vs. 13 
Functional gastrointestinal disorders and type 2 diabetes risk
In age-adjusted models (M 0 , 
Mediation by body mass index
The associations between constipation and alternation of diarrhea and constipation, and risk of T2D 
Other sensitivity analyses
To test the hypothesis of potential reverse causation, we evaluated the associations between FGID and T2D by excluding cases in the first five years of follow-up and results were similar. Similarly, we also computed Cox models starting in 1995 instead of 1993, where information on the use of laxatives and psychotropic drugs was available. Adjustment for these potential confounders did not alter the associations observed.
CONCLUSIONS
In the large prospective E3N-EPIC cohort study, we showed for the first time an association between FGID and T2D risk. Women with chronic diarrhea were found to be at increased risk of T2D when compared to those with normal gastrointestinal transit, whereas those with chronic constipation had a marked decrease in T2D risk. These associations were found to be independent of established T2D risk f, of dietary habits such as coffee or fruit and vegetable consumption, and even of the use of laxatives and psychotropic drugs. The association with diarrhea was found to be mediated partly by adiposity since, after controlling for BMI, only chronic constipation and alternation diarrheaconstipation were still associated with a respectively decreased and increased T2D risk. Moreover, we have found consistent patterns of risk for diarrhea and constipation when looking at overweight as the outcome instead of T2D. These results are in favor of both a direct mechanism between FGID and T2D and an indirect one through adiposity.
Potential mechanisms
To our knowledge, this is the first study to investigate the association between FGID and T2D risk.
Mechanisms in relation to the gut microbiota and inflammation could explain, at least partly, our
results. An altered gut microbiota has been linked to obesity and T2D. 23, 24 Individuals with chronic FGID are suggested to have a different microbial ecology compared to those with normal gastrointestinal transit, which could in turn result in different risks for T2D. 19 The intestinal microbial community can affect the rate of deposition and utilization of fat, insulin resistance and diabetes, as well as an inflammation state. 19, 25 It is known that the gut microbiota participates in the overall body metabolism by affecting energy balance, glucose metabolism and lowgrade inflammation associated with obesity and related metabolic disorders such as T2D. 26 It has been shown that transfer of intestinal microbiota can modulate insulin sensitivity in individuals with metabolic syndrome. 27 Translocation of gut microbiota, particularly endotoxins or lipopolysaccharides on the surface of gram-negative bacteria to the systemic circulation, has been proposed to induce inflammation and insulin resistance. 24 In mouse, commensal gut bacteria translocate to mesenteric adipose tissue, initiating low-grade inflammation before the onset of insulin resistance and type 2 diabetes. 28 However, the present epidemiological study was not designed to properly address the impact of gut microbiota on both FGID and the risk of diabetes. Further complimentary studies are warranted to test this hypothesis.
Limitations and advantages
This study has some limitations. Although we adjusted for many type 2 diabetes risk factors, some residual confounding cannot be completely ruled out. Our study population included only women.
Even if some previous studies have reported a higher prevalence of FGID in women, 3 there is no biological ground to suggest indicate that the association with T2D is restricted to women.
This study has also numerous strengths. The large number of cases enabled us to have a high statistical power to detect associations. The dietary questionnaire of the E3N-EPIC cohort study provided detailed information on the women's diet, thus enabling us to adjust for potential confounders. Moreover, we analyzed validated incident type 2 diabetes cases only, based on a welldefined validation algorithm, which reduced the risk of missing cases or of false-positive cases. Some residual misclassifications with respect to diabetes status may exist, but it is likely to be nondifferential with regard to FGID.
Lastly, the prospective design and the long follow-up in the E3N-EPIC cohort allowed us to perform sensitivity analyses while maintaining sufficient statistical power, making a reverse causation hypothesis unlikely.
Conclusion
The study showed for the first time an association between some FGID and T2D risk in a large prospective cohort study, which supports the hypothesis of a relationship between gastrointestinal functions and the development of diabetes. The presence of gastrointestinal transit disorders could assist in the screening of subjects at higher risk of diabetes, independently of classical risk factors.
These findings need to be confirmed in other populations and these results may prompt future research, in particular the assessment of the influence of microbiota on the risk of diabetes in individuals with FGID.
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